NCT02290288

Brief Summary

The study is carried out at the Sahlgrenska University Hospital and the patient population consists of women referred with symptomatic and bothersome post-hysterectomy vaginal vault prolapse at least 1 cm above or beyond the hymeneal remnants. The interventions are either vaginal sacrospinousfixation or laparoscopic sacrocolpopexy following randomization to one of the types of surgery. The primary outcome is anatomical failure based on clinical assessment. Failure is defined clinically, according to the Pelvic Organ Prolapse Quantification system, as Ba, C or Bp at the hymen or below on maximum Valsalva maneuver one and two years after the surgery. Secondary outcomes are evaluation of continence, sexual function and prolapse symptoms based on validated questionnaires 1, 2, 5 and 10 years after the surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2005

Completed
9.1 years until next milestone

First Submitted

Initial submission to the registry

November 4, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 14, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

May 19, 2015

Status Verified

May 1, 2015

Enrollment Period

9.6 years

First QC Date

November 4, 2014

Last Update Submit

May 18, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • anatomical failure (Failure was defined clinically as Ba, C or Bp at the hymen or below, on maximum Valsalva maneuver.)

    The primary outcome measure was anatomical failure based on clinical assessment. Failure was defined clinically as Ba, C or Bp at the hymen or below, on maximum Valsalva maneuver.

    1 year

Secondary Outcomes (4)

  • continence status

    1 and 5 years

  • sexual function

    1 and 5 years

  • prolapse symptoms

    1 and 5 years

  • quality of life

    1 and 5 years

Study Arms (2)

SSF

ACTIVE COMPARATOR

1\. vaginal surgery arm (SSF)

Procedure: vaginal surgery

LSC

ACTIVE COMPARATOR

laparoscopic surgery arm (LSC)

Procedure: laparoscopic surgery

Interventions

SSF

Eligibility Criteria

Age40 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • post-hysterectomy patients with at least two-compartment prolapse (with affected apical/vault compartment,
  • stage II or higher on the Pelvic Organ Prolapse Quantification system (POP-Q)),
  • suffering from symptoms of prolapse,
  • requesting pelvic floor reconstructive surgery, and
  • diagnosed with a vault prolapse.

You may not qualify if:

  • patients with prolapse and uterus in place,
  • those not requesting pelvic floor surgery,
  • patients who do not understand Swedish or are not capable to fulfill follow up procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept of Obst Gyn, Sahlgrenska University Hospital

Gothenburg, VGR, 41381, Sweden

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
senior consultant

Study Record Dates

First Submitted

November 4, 2014

First Posted

November 14, 2014

Study Start

October 1, 2005

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

May 19, 2015

Record last verified: 2015-05

Locations